593642342	593642342	CD	B-NP	O
|	|	NN	I-NP	O
HSPHAC	HSPHAC	NN	I-NP	O
|	|	NN	I-NP	O
60037013	60037013	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
3961566	3961566	CD	B-NP	O
|	|	CC	I-NP	O
11/7/2007	11/7/2007	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/26/2007	10/26/2007	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
ATTENDING	ATTENDING	NN	B-NP	O
:	:	:	O	O
TELLES	TELLES	NNS	B-NP	O
,	,	,	O	O
MARCELO	MARCELO	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
ADMITTING	ADMITTING	NNP	I-NP	O
INTERN	INTERN	NNP	I-NP	O
:	:	:	O	O
Darrin	Darrin	NNP	B-NP	O
Strzyzewski	Strzyzewski	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
ADMITTING	ADMITTING	NNP	I-NP	O
RESIDENT	RESIDENT	NNP	I-NP	O
:	:	:	O	O
Rigoberto	Rigoberto	NNP	B-NP	O
Shuford	Shuford	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
ESTIMATED	ESTIMATED	NNP	I-NP	O
DATE	DATE	NNP	I-NP	O
OF	OF	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
:	:	:	O	O
4/5/07	4/5/07	CD	B-NP	O
.	.	.	O	O

PRINCIPAL	PRINCIPAL	JJ	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Congestive	Congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
amyloid	amyloid	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
pneumonia	pneumonia	NN	B-NP	O
.	.	.	O	O

SECONDARY	SECONDARY	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
Include	Include	VBP	B-VP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
left	leave	VBD	B-VP	O
BKA	BKA	NN	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
pacemaker	pacemaker	NN	I-NP	O
for	for	IN	B-PP	O
sick	sick	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
pseudogout	pseudogout	NN	B-NP	O
,	,	,	O	O
spinal	spinal	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
88-year-old	88-year-old	JJ	I-NP	O
Tere	Tere	NNP	I-NP	O
All	All	NNP	I-NP	O
War	War	NNP	I-NP	O
male	male	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
with	with	IN	B-PP	O
an	an	DT	B-NP	O
estimated	estimate	VBN	I-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
45-50	45-50	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	I-NP	O
diastolic	diastolic	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
,	,	,	O	O
also	also	RB	B-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
CVA	CVA	NN	I-NP	B-protein
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
recently	recently	RB	I-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Tiesville	Tiesville	NNP	I-NP	O
Caing	Caing	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
CHF	CHF	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
the	the	DT	B-NP	O
recent	recent	JJ	I-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
Lasix	Lasix	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
from	from	IN	B-PP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
to	to	TO	B-PP	O
80	80	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
During	During	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
ultrasounds	ultrasound	NNS	I-NP	O
for	for	IN	B-PP	O
right	right	JJ	B-NP	O
leg	leg	NN	I-NP	O
edema	edema	NN	I-NP	O
and	and	CC	O	O
chronic	chronic	JJ	B-NP	O
swelling	swelling	NN	I-NP	O
and	and	CC	B-PP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
with	with	IN	B-PP	O
Lasix	Lasix	NN	B-NP	O
and	and	CC	O	O
discharged	discharge	VBD	B-VP	O
home	home	NN	B-NP	O
on	on	IN	B-PP	O
6/28/07	6/28/07	CD	B-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
experienced	experience	VBD	B-VP	O
increasing	increase	VBG	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
PND	PND	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
VNA	VNA	NN	I-NP	B-protein
who	who	WP	B-NP	O
visited	visit	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
noted	note	VBD	B-VP	O
a	a	DT	B-NP	O
fever	fever	NN	I-NP	O
of	of	IN	B-PP	O
101	101	CD	B-NP	O
Fahrenheit	Fahrenheit	NN	I-NP	O
and	and	CC	B-PP	O
so	so	IN	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
went	go	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Department	Department	NNP	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Department	Department	NNP	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
,	,	,	O	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
80	80	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
130/80s	130/80	NNS	I-NP	O
,	,	,	O	O
respirations	respiration	NNS	B-NP	O
16	16	CD	B-NP	O
satting	satte	VBG	B-VP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2-4	2-4	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
oxygen	oxygen	NN	I-NP	O
requirement	requirement	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
crackles	crackle	NNS	B-NP	O
on	on	IN	B-PP	O
exam	exam	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
showed	show	VBD	B-VP	O
improved	improved	JJ	B-NP	O
effusions	effusion	NNS	I-NP	O
from	from	IN	B-PP	O
prior	prior	JJ	O	O
but	but	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
pneumonia	pneumonia	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
right	right	JJ	I-NP	O
leg	leg	NN	I-NP	O
was	be	VBD	B-VP	O
still	still	RB	I-VP	O
swollen	swell	VBN	I-VP	O
but	but	CC	O	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
prior	prior	JJ	B-ADJP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Room	Room	NNP	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NNP	I-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
and	and	CC	O	O
750	750	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	B-protein
x1	x1	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Cardiology	Cardiology	NNP	I-NP	O
Service	Service	NNP	I-NP	O
for	for	IN	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
.	.	.	O	O

HOME	HOME	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Tylenol	Tylenol	NN	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
every	every	DT	B-NP	O
daily	daily	JJ	I-NP	O
,	,	,	I-NP	O
diltiazem	diltiazem	NN	I-NP	O
extended	extend	VBD	B-VP	O
release	release	NN	B-NP	O
120	120	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
iron	iron	NN	B-NP	O
sulfate	sulfate	NN	I-NP	O
325	325	CD	B-NP	O
mg	mg	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
daily	daily	JJ	I-NP	O
,	,	,	I-NP	O
folic	folic	JJ	I-NP	O
acid	acid	NN	I-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
gabapentin	gabapentin	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
20	20	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcutaneously	subcutaneously	RB	B-ADVP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
regular	regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
Xalatan	Xalatan	NN	B-NP	O
eye	eye	NN	I-NP	O
drops	drop	VBZ	B-VP	O
one	one	CD	B-NP	O
drop	drop	NN	I-NP	O
each	each	DT	B-NP	O
eye	eye	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
metoprolol	metoprolol	NN	B-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
senna	senna	NN	B-NP	O
tablets	tablet	NNS	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
simvastatin	simvastatin	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
IV	IV	CD	B-NP	O
contrast	contrast	NN	I-NP	O
and	and	CC	I-NP	O
latex	latex	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
retired	retired	JJ	I-NP	B-protein
cook	cook	NN	I-NP	I-protein
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
originally	originally	RB	B-ADVP	O
from	from	IN	B-PP	O
E	E	NNP	B-NP	O
Vi	Vi	NNP	I-NP	O
He	He	NNP	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
past	past	JJ	B-NP	O
tobacco	tobacco	NN	I-NP	O
use	use	NN	I-NP	O
,	,	,	O	O
quit	quit	VBD	B-VP	O
30	30	CD	B-NP	O
years	year	NNS	I-NP	O
ago	ago	IN	B-ADVP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
drank	drank	NN	I-NP	O
alcohol	alcohol	NN	I-NP	O
rarely	rarely	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
wheelchair-bound	wheelchair-bound	JJ	B-ADJP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
lives	live	VBZ	B-VP	O
alone	alone	RB	B-ADVP	O
.	.	.	O	O

VNA	VNA	NN	B-NP	B-protein
visits	visit	VBZ	B-VP	O
him	him	PRP	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
three	three	CD	B-NP	O
daughters	daughter	NNS	I-NP	O
in	in	IN	B-PP	O
Vale	Vale	NNP	B-NP	O
,	,	,	O	O
Georgia	Georgia	NNP	B-NP	O
FAMILY	FAMILY	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
notes	note	VBZ	B-VP	O
there	there	EX	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
no	no	DT	B-NP	O
one	one	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
immediate	immediate	JJ	I-NP	B-protein
family	family	NN	I-NP	I-protein
who	who	WP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
MI	MI	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NNP	B-NP	O
EXAMINATION	EXAMINATION	NNP	I-NP	O
ON	ON	NNP	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
VITAL	VITAL	JJ	B-NP	O
SIGNS	SIGNS	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	O
of	of	IN	B-PP	O
100.0	100.0	CD	B-NP	O
Fahrenheit	Fahrenheit	NN	I-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
71	71	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
116/64	116/64	CD	I-NP	O
satting	satte	VBG	B-VP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
nasal	nasal	JJ	I-NP	O
cannula	cannula	NN	I-NP	O
oxygen	oxygen	NN	I-NP	O
respirations	respiration	NNS	I-NP	O
16	16	CD	B-NP	O
.	.	.	O	O

GENERAL	GENERAL	NN	B-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
,	,	,	O	O
lying	lie	VBG	B-VP	O
bed	bed	NN	B-NP	O
,	,	,	O	O
speaking	speak	VBG	B-VP	O
in	in	IN	B-PP	O
full	full	JJ	B-NP	O
sentences	sentence	NNS	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
OP	OP	NN	B-NP	O
clear	clear	JJ	B-ADJP	O
without	without	IN	B-PP	O
erythema	erythema	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
dentures	denture	NNS	B-NP	O
.	.	.	O	O

Pupils	Pupil	NNS	B-NP	O
were	be	VBD	B-VP	O
equal	equal	JJ	B-ADJP	O
,	,	,	I-ADJP	O
round	round	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
reactive	reactive	JJ	I-ADJP	O
.	.	.	O	O

Extraocular	Extraocular	JJ	B-NP	O
muscle	muscle	NN	I-NP	O
was	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

NECK	NECK	NN	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
carotid	carotid	NN	I-NP	O
bruits	bruit	NNS	I-NP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	O
was	be	VBD	B-VP	O
supple	supple	NN	B-NP	O
.	.	.	O	O

JVP	JVP	NN	B-NP	B-protein
listed	list	VBN	B-VP	O
in	in	IN	B-PP	O
chart	chart	NN	B-NP	O
as	as	IN	B-PP	O
12	12	CD	B-NP	O
cm	cm	NN	I-NP	O
CARDIOVASCULAR	CARDIOVASCULAR	NN	I-NP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
II/VI	II/VI	NNP	B-NP	O
systolic	systolic	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lower	low	JJR	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
.	.	.	O	O

RESPIRATION	RESPIRATION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
crackles	crackle	NNS	B-NP	O
half	half	DT	B-NP	O
way	way	NN	I-NP	O
up	up	RP	B-PRT	O
each	each	DT	B-NP	O
lung	lung	NN	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
egophony	egophony	NN	I-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
dullness	dullness	NN	I-NP	O
to	to	TO	B-PP	O
percussion	percussion	NN	B-NP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
:	:	:	O	O
Positive	Positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
soft	soft	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
nontender	nontender	JJ	I-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
mild	mild	JJ	I-NP	O
distention	distention	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
masses	mass	NNS	I-NP	O
.	.	.	O	O

EXTREMITIES	EXTREMITIES	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
BKA	BKA	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
right	right	JJ	I-NP	O
leg	leg	NN	I-NP	O
showed	show	VBD	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	B-NP	O
pitting	pit	VBG	B-VP	O
edema	edema	NN	B-NP	O
halfway	halfway	NN	I-NP	O
up	up	RP	B-PRT	O
his	his	PRP$	B-NP	O
anterior	anterior	JJ	I-NP	O
shin	shin	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
left	left	JJ	I-NP	O
leg	leg	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
ulceration	ulceration	NN	I-NP	O
or	or	CC	I-NP	O
lacerations	laceration	NNS	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
tenderness	tenderness	NN	I-NP	O
.	.	.	O	O

NEURO	NEURO	NN	B-NP	B-protein
:	:	:	O	O
Alert	Alert	NNP	B-NP	O
and	and	CC	O	O
oriented	orient	VBN	B-NP	O
x3	x3	NN	I-NP	O
.	.	.	O	O

Cranial	Cranial	NNP	B-NP	O
nerves	nerve	VBZ	B-VP	O
II	II	CD	B-NP	O
through	through	IN	B-PP	O
XII	XII	CD	B-NP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

Generally	Generally	RB	B-ADVP	O
,	,	,	O	O
nonfocal	nonfocal	JJ	B-NP	O
exam	exam	NN	I-NP	O
.	.	.	O	O

REVIEW	REVIEW	NNP	B-NP	O
OF	OF	IN	B-PP	O
SYSTEMS	SYSTEMS	NNP	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
minimal	minimal	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
couple	couple	NN	I-NP	O
of	of	IN	B-PP	O
days	day	NNS	B-NP	O
only	only	RB	B-ADVP	O
with	with	IN	B-PP	O
cough	cough	NN	B-NP	O
,	,	,	O	O
otherwise	otherwise	RB	B-NP	O
no	no	DT	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
chest	chest	NN	B-NP	O
pain-free	pain-free	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Room	Room	NNP	I-NP	O
and	and	CC	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
nausea	nausea	NN	I-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
diaphoresis	diaphoresis	NN	B-NP	O
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
rash	rash	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
diarrhea	diarrhea	NN	I-NP	O
,	,	,	O	O
positive	positive	JJ	B-NP	O
constipation	constipation	NN	I-NP	O
,	,	,	O	O
increased	increase	VBD	B-VP	O
leg	leg	NN	B-NP	O
swelling	swell	VBG	B-VP	O
since	since	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
hematuria	hematuria	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
dysuria	dysuria	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
productive	productive	JJ	I-NP	O
cough	cough	NN	I-NP	O
of	of	IN	B-PP	O
clear	clear	JJ	B-NP	O
phlegm	phlegm	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
hemoptysis	hemoptysis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
good	good	JJ	I-NP	O
medication	medication	NN	I-NP	O
compliance	compliance	NN	I-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
LABS	LABS	NN	I-NP	O
:	:	:	O	O
Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
1.1	1.1	CD	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
at	at	IN	B-PP	O
his	his	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
of	of	IN	B-PP	O
35.2	35.2	CD	B-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
hematocrit	hematocrit	NN	I-NP	O
is	be	VBZ	B-VP	O
between	between	IN	B-PP	O
31	31	CD	B-NP	O
and	and	CC	I-NP	O
32	32	CD	I-NP	O
.	.	.	O	O

BNP	BNP	NN	B-NP	B-protein
was	be	VBD	B-VP	O
570	570	CD	B-NP	O
.	.	.	O	O

Troponin	Troponin	NN	B-NP	B-protein
was	be	VBD	B-VP	O
0.78	0.78	CD	B-NP	O
,	,	,	O	O
AST	AST	NN	B-NP	O
62	62	CD	I-NP	O
,	,	,	O	O
ALT	ALT	NN	B-NP	B-DNA
26	26	CD	I-NP	I-DNA
,	,	,	O	O
alkaline	alkaline	NN	B-NP	O
phosphatase	phosphatase	NN	I-NP	O
183	183	CD	I-NP	O
,	,	,	O	O
albumin	albumin	NN	B-NP	B-protein
3.6	3.6	CD	I-NP	I-protein
.	.	.	O	O

Admission	Admission	NN	B-NP	O
EKG	EKG	NN	I-NP	O
was	be	VBD	B-VP	O
V-paced	V-paced	JJ	B-ADJP	O
with	with	IN	B-PP	O
left	left	JJ	B-NP	O
axis	axis	NN	I-NP	O
deviation	deviation	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
ST-T	ST-T	NN	I-NP	O
wave	wave	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
prior	prior	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
EKG	EKG	NN	I-NP	B-protein
.	.	.	O	O

Admission	Admission	NN	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
from	from	IN	B-PP	O
10/30/07	10/30/07	CD	B-NP	O
,	,	,	O	O
decreased	decrease	VBN	B-NP	O
size	size	NN	I-NP	O
small	small	JJ	I-NP	O
bilateral	bilateral	JJ	I-NP	O
effusions	effusion	NNS	I-NP	O
,	,	,	O	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
segmental	segmental	JJ	I-NP	O
bibasilar	bibasilar	JJ	I-NP	O
atelectasis	atelectasis	NN	I-NP	O
versus	versus	IN	B-PP	O
consolidation	consolidation	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
frank	frank	NN	I-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
.	.	.	O	O

CONSULTANTS	CONSULTANTS	NNS	B-NP	O
:	:	:	O	O
Hematology	Hematology	NN	B-NP	O
of	of	IN	B-PP	O
BH	BH	NNP	B-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Bradley	Bradley	NNP	I-NP	O
Ebanks	Ebanks	NNP	I-NP	O
.	.	.	O	O

ASSESSMENT	ASSESSMENT	NN	B-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
88-year-old	88-year-old	JJ	I-NP	O
Co	Co	NNP	I-NP	O
Louis	Louis	NNP	I-NP	O
Awestinsde	Awestinsde	NNP	I-NP	O
male	male	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
increasing	increase	VBG	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
CHF	CHF	NN	B-NP	B-protein
and	and	CC	O	O
also	also	RB	B-VP	O
presented	present	VBD	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
fever	fever	NN	I-NP	O
concerning	concern	VBG	B-VP	O
for	for	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
amyloid	amyloid	NN	B-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
PROBLEM	PROBLEM	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	NNP	B-NP	O
:	:	:	O	O
A.	A.	NNP	B-NP	O
Ischemia	Ischemia	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
known	know	VBN	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
CAD	CAD	NN	B-NP	B-protein
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
many	many	JJ	B-NP	O
risk	risk	NN	I-NP	O
factors	factor	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
troponin	troponin	NN	I-NP	O
of	of	IN	B-PP	O
0.7	0.7	CD	B-NP	O
on	on	IN	B-PP	O
admit	admit	NN	B-NP	O
which	which	WDT	B-NP	O
subsequently	subsequently	RB	B-ADVP	O
trended	trend	VBD	B-VP	O
down	down	RB	B-ADVP	O
.	.	.	O	O

This	This	DT	B-NP	O
troponin	troponin	NN	I-NP	O
leak	leak	NN	I-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-VP	O
demand	demand	VB	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
chest	chest	NN	B-ADJP	O
pain-free	pain-free	JJ	I-ADJP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
entire	entire	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
ischemic	ischemic	JJ	I-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
aspirin	aspirin	NN	I-NP	O
,	,	,	I-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
and	and	CC	I-NP	O
statin	statin	NN	I-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

B.	B.	NNP	B-NP	O
Pump	Pump	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
with	with	IN	B-PP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
40-45	40-45	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
presumably	presumably	RB	I-VP	O
attributed	attribute	VBN	I-VP	O
to	to	TO	B-PP	O
ischemic	ischemic	JJ	B-NP	O
for	for	IN	B-PP	O
hypertensive	hypertensive	JJ	B-NP	O
etiology	etiology	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
biopsy	biopsy	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
amyloid	amyloid	NN	B-NP	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
amyloid	amyloid	NN	B-NP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
cause	cause	NN	I-NP	O
underlying	underlie	VBG	B-VP	O
his	his	PRP$	B-NP	O
CHF	CHF	NN	I-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
appeared	appear	VBD	B-VP	O
mildly	mildly	RB	B-ADJP	O
fluid	fluid	JJ	I-ADJP	O
overloaded	overload	VBN	B-VP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
successfully	successfully	RB	I-VP	O
diuresed	diurese	VBN	I-VP	O
with	with	IN	B-PP	O
100	100	CD	B-NP	O
IV	IV	CD	I-NP	O
Lasix	Lasix	NN	I-NP	O
for	for	IN	B-PP	O
several	several	JJ	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
switched	switch	VBN	I-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
of	of	IN	B-PP	O
80	80	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
euvolemic	euvolemic	JJ	B-ADJP	O
for	for	IN	B-PP	O
several	several	JJ	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
discharge	discharge	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
euvolemic	euvolemic	JJ	I-NP	O
weight	weight	NN	I-NP	O
on	on	IN	B-PP	O
8/10/07	8/10/07	CD	B-NP	O
was	be	VBD	B-VP	O
64.5	64.5	CD	B-NP	O
kilograms	kilogram	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
discharge	discharge	NN	I-NP	O
weight	weight	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
reported	report	VBN	I-VP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
addendum	addendum	NN	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
calcium	calcium	NN	I-NP	O
channel	channel	NN	I-NP	O
blocker	blocker	NN	I-NP	O
and	and	CC	I-NP	O
diltiazem	diltiazem	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
given	give	VBN	B-VP	O
his	his	PRP$	B-NP	O
likely	likely	JJ	I-NP	O
restrictive	restrictive	JJ	I-NP	O
heart	heart	NN	I-NP	O
physiology	physiology	NN	I-NP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
new	new	JJ	I-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
amyloid	amyloid	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
nitrate	nitrate	NN	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
reduce	reduce	VB	I-VP	O
preload	preload	NN	B-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
mentioned	mention	VBN	B-VP	O
above	above	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
catheterization	catheterization	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
endomyocardial	endomyocardial	JJ	I-NP	O
biopsy	biopsy	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
amyloid	amyloid	JJ	B-ADJP	O
.	.	.	O	O

A	A	DT	B-NP	O
panel	panel	NN	I-NP	O
of	of	IN	B-PP	O
other	other	JJ	B-NP	O
amyloid-related	amyloid-related	JJ	I-NP	O
tests	test	NNS	I-NP	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
sent	send	VBN	I-VP	O
out	out	RP	B-PRT	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
serum	serum	NN	B-NP	O
genetic	genetic	JJ	I-NP	O
amyloid	amyloid	JJ	I-NP	O
testing	testing	NN	I-NP	O
was	be	VBD	B-VP	O
pending	pende	VBG	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
serum	serum	NN	I-NP	O
immunofixation	immunofixation	NN	I-NP	O
test	test	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
urine	urine	NN	I-NP	O
immunofixation	immunofixation	NN	I-NP	O
test	test	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	O
monoclonal	monoclonal	JJ	I-NP	O
spike	spike	NN	I-NP	O
with	with	IN	B-PP	O
Lambda	Lambda	NNP	B-NP	B-protein
light	light	JJ	I-NP	I-protein
chain	chain	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
serum-free	serum-free	JJ	I-NP	O
light	light	JJ	I-NP	O
chain	chain	NN	I-NP	O
assay	assay	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
equivocal/positive	equivocal/positive	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
positive	positive	JJ	B-NP	O
proteinuria	proteinuria	NN	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
spot	spot	NN	I-NP	O
urine	urine	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
bone	bone	NN	I-NP	O
marrow	marrow	NN	I-NP	O
biopsy	biopsy	NN	I-NP	O
done	do	VBN	B-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Jarred	Jarred	NNP	I-NP	O
Canner	Canner	NNP	I-NP	O
of	of	IN	B-PP	O
MOMH	MOMH	NN	B-NP	B-protein
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
further	further	RB	I-VP	O
define	define	VB	I-VP	O
this	this	DT	B-NP	O
subtype	subtype	NN	I-NP	O
of	of	IN	B-PP	O
amyloid	amyloid	NN	B-NP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
and	and	CC	O	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
facilitate	facilitate	VB	I-VP	O
a	a	DT	B-NP	O
screening	screening	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	B-protein
family	family	NN	I-NP	I-protein
members	member	NNS	I-NP	I-protein
for	for	IN	B-PP	O
amyloid	amyloid	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
bone	bone	NN	I-NP	O
marrow	marrow	NN	I-NP	O
biopsy	biopsy	NN	I-NP	O
given	give	VBN	B-VP	O
the	the	DT	B-NP	O
monoclonal	monoclonal	JJ	I-NP	O
spike	spike	NN	I-NP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
urine	urine	NN	I-NP	O
immunofixation	immunofixation	NN	I-NP	O
test	test	NN	I-NP	O
.	.	.	O	O

C.	C.	NNP	B-NP	O
Rhythm	Rhythm	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
originally	originally	RB	B-ADVP	O
put	put	VBD	B-VP	O
in	in	RP	B-PRT	O
for	for	IN	B-PP	O
sick	sick	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
V-paced	V-paced	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discovered	discover	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
7/9/07	7/9/07	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
EP	EP	NNP	I-NP	O
Service	Service	NNP	I-NP	O
changed	change	VBD	B-VP	O
the	the	DT	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
setting	set	VBG	B-VP	O
to	to	TO	B-PP	O
VVI	VVI	NN	B-NP	B-protein
given	give	VBN	B-PP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
and	and	CC	O	O
decreased	decrease	VBD	B-VP	O
the	the	DT	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
60s-70s	60s-70	NNS	I-NP	B-DNA
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
throughout	throughout	IN	B-PP	O
his	his	PRP$	B-NP	O
stay	stay	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
uneventful	uneventful	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
for	for	IN	B-PP	O
anticoagulation	anticoagulation	NN	B-NP	O
given	give	VBN	B-VP	O
his	his	PRP$	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
amyloid	amyloid	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
subtherapeutic	subtherapeutic	JJ	B-ADJP	O
and	and	CC	O	O
on	on	IN	B-PP	O
7/11/07	7/11/07	CD	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
still	still	RB	B-ADJP	O
subtherapeutic	subtherapeutic	JJ	I-ADJP	O
at	at	IN	B-PP	O
1.5	1.5	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
will	will	MD	B-VP	O
most	most	RBS	I-VP	O
likely	likely	RB	I-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
3.5	3.5	CD	I-NP	O
mg	mg	NN	I-NP	O
every	every	DT	B-NP	O
evening	evening	NN	I-NP	O
which	which	WDT	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
adjusted	adjust	VBN	I-VP	O
as	as	RB	B-ADJP	O
necessary	necessary	JJ	I-ADJP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Rehabilitation	Rehabilitation	NN	I-NP	O
Facility	Facility	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
Disease	Disease	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
mild	mild	JJ	I-NP	O
cough	cough	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
fever	fever	NN	I-NP	O
on	on	IN	B-PP	O
admit	admit	NN	B-NP	O
but	but	CC	O	O
was	be	VBD	B-VP	O
afebrile	afebrile	RB	B-ADVP	O
after	after	IN	B-PP	O
one	one	CD	B-NP	O
to	to	TO	B-PP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
on	on	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
leukocytosis	leukocytosis	NN	I-NP	O
.	.	.	O	O

Again	Again	RB	B-ADVP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
clinical	clinical	JJ	I-NP	O
findings	finding	NNS	I-NP	O
were	be	VBD	B-VP	O
suspicious	suspicious	JJ	B-ADJP	O
for	for	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
five-day	five-day	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
at	at	IN	B-PP	O
750	750	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
ended	end	VBN	B-VP	O
on	on	IN	B-PP	O
1/27/07	1/27/07	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
blood	blood	NN	B-NP	O
,	,	,	I-NP	O
urine	urine	NN	I-NP	O
and	and	CC	I-NP	O
sputum	sputum	NN	I-NP	O
cultures	culture	NNS	I-NP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
baseline	baseline	NN	B-NP	O
anemia	anemia	NN	I-NP	O
between	between	IN	B-PP	O
hematocrit	hematocrit	NN	B-NP	O
of	of	IN	B-PP	O
31	31	CD	B-NP	O
and	and	CC	I-NP	O
32	32	CD	I-NP	O
which	which	WDT	B-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
thrombocytopenia	thrombocytopenia	NN	I-NP	O
with	with	IN	B-PP	O
platelets	platelet	NNS	B-NP	B-cell_type
at	at	IN	B-PP	O
approximately	approximately	RB	B-NP	O
170	170	CD	I-NP	O
which	which	WDT	B-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
his	his	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
and	and	CC	O	O
again	again	RB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
as	as	IN	B-SBAR	O
stated	state	VBN	B-VP	O
above	above	IN	B-ADVP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
for	for	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
and	and	CC	B-PP	O
for	for	IN	B-PP	O
amyloid	amyloid	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
was	be	VBD	B-VP	O
slowly	slowly	RB	I-VP	O
increased	increase	VBN	I-VP	O
up	up	IN	B-NP	O
to	to	TO	I-NP	O
3.5	3.5	CD	I-NP	O
mg	mg	NN	I-NP	O
given	give	VBN	B-VP	O
subtherapeutic	subtherapeutic	JJ	B-NP	O
INR	INR	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
bone	bone	NN	I-NP	O
marrow	marrow	NN	I-NP	O
biopsy	biopsy	NN	I-NP	O
done	do	VBN	B-VP	O
on	on	IN	B-PP	O
5/10/07	5/10/07	CD	B-NP	O
as	as	IN	B-SBAR	O
mentioned	mention	VBN	B-VP	O
above	above	RB	B-ADVP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
further	further	RB	I-VP	O
define	define	VB	I-VP	O
the	the	DT	B-NP	O
amyloid	amyloid	NN	I-NP	O
?	?	.	O	O
?	?	.	O	O
_	_	''	O	B-cell_line
?	?	.	O	O
?	?	.	O	O
and	and	CC	O	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
the	the	DT	B-NP	O
monoclonal	monoclonal	JJ	I-NP	O
spike	spike	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
urine	urine	NN	I-NP	O
immunofixation	immunofixation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
final	final	JJ	I-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
bone	bone	NN	I-NP	O
marrow	marrow	NN	I-NP	O
biopsy	biopsy	NN	I-NP	O
are	be	VBP	B-VP	O
pending	pende	VBG	B-ADJP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
diabetes	diabete	NNS	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
first	first	JJ	B-ADJP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
NPH	NPH	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
20	20	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneous	subcutaneous	JJ	B-ADJP	O
daily	daily	RB	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
an	an	DT	B-NP	O
insulin	insulin	NN	I-NP	B-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

Because	Because	IN	B-PP	O
of	of	IN	I-PP	O
persistent	persistent	JJ	B-NP	O
hypoglycemia	hypoglycemia	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
NPH	NPH	NN	I-NP	B-protein
was	be	VBD	B-VP	O
reduced	reduce	VBN	I-VP	O
to	to	TO	B-PP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
NPH	NPH	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
subcutaneous	subcutaneous	JJ	B-ADJP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

FEN	FEN	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
low-salt	low-salt	JJ	I-NP	O
diet	diet	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
2-liter	2-liter	JJ	I-NP	O
fluid	fluid	NN	I-NP	O
restriction	restriction	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
Nutrition	Nutrition	NN	B-NP	O
inhouse	inhouse	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
approximately	approximately	RB	B-NP	O
1.0	1.0	CD	I-NP	O
which	which	WDT	B-NP	O
stayed	stay	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
his	his	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
chronic	chronic	JJ	B-NP	O
LFT	LFT	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
CHF	CHF	NN	B-NP	B-protein
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
etiology	etiology	NN	I-NP	O
is	be	VBZ	B-VP	O
uncertain	uncertain	JJ	B-ADJP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Question	Question	NN	B-NP	O
restless	restless	JJ	I-NP	O
leg	leg	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
2/19/07	2/19/07	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
complaining	complain	VBG	I-VP	O
of	of	IN	B-PP	O
myoclonic	myoclonic	JJ	B-NP	O
jerks	jerk	NNS	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	O
leg	leg	NN	I-NP	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
old	old	JJ	I-NP	O
problem	problem	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
general	general	JJ	I-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
a	a	DT	B-NP	O
trial	trial	NN	I-NP	O
of	of	IN	B-PP	O
magnesium	magnesium	NN	B-NP	O
supplementation	supplementation	NN	I-NP	O
inhouse	inhouse	NN	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Low	Low	RB	B-ADVP	O
back	back	RB	I-ADVP	O
,	,	,	O	O
sacral	sacral	JJ	B-NP	O
pain	pain	NN	I-NP	O
:	:	:	O	O
His	His	PRP$	B-NP	O
low	low	JJ	I-NP	O
back	back	JJ	I-NP	O
pain	pain	NN	I-NP	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
chronic	chronic	JJ	B-ADJP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
oxycodone	oxycodone	NN	B-NP	O
successfully	successfully	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
skin	skin	NN	I-NP	O
tear	tear	NN	I-NP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	O
buttock	buttock	NN	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
DuoDERM	DuoDERM	NN	I-NP	B-protein
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
over	over	IN	B-PP	O
it	it	PRP	B-NP	O
for	for	IN	B-PP	O
wound	wound	NN	B-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
stage	stage	NN	I-NP	O
I	I	CD	I-NP	O
sacral	sacral	JJ	I-NP	O
decubitus	decubitus	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
DuoDERM	DuoDERM	NN	I-NP	B-protein
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
it	it	PRP	B-NP	O
for	for	IN	B-PP	O
wound	wound	NN	B-NP	O
care	care	NN	I-NP	O
and	and	CC	B-PP	O
for	for	IN	B-PP	O
protection	protection	NN	B-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
DVT	DVT	NN	B-NP	O
dose	dose	NN	I-NP	O
Lovenox	Lovenox	NN	I-NP	O
inhouse	inhouse	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Physical	Physical	JJ	B-NP	O
Therapy	Therapy	NN	I-NP	O
:	:	:	O	O
Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
BKA	BKA	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
family	family	NN	I-NP	O
brought	bring	VBD	B-VP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
prosthetic	prosthetic	JJ	I-NP	O
leg	leg	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
his	his	PRP$	B-NP	O
walker	walker	NN	I-NP	O
.	.	.	O	O

Physical	Physical	JJ	B-NP	O
Therapy	Therapy	NN	I-NP	O
inhouse	inhouse	NN	I-NP	O
worked	work	VBD	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
determined	determine	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
unsafe	unsafe	JJ	B-ADJP	O
to	to	TO	B-VP	O
go	go	VB	I-VP	O
home	home	NN	B-ADVP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
recommended	recommend	VBN	I-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
go	go	VB	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
facility	facility	NN	I-NP	O
to	to	TO	B-PP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
finally	finally	RB	B-ADVP	O
agreed	agree	VBD	B-VP	O
.	.	.	O	O

CODE	CODE	NN	B-NP	O
STATUS	STATUS	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
full	full	JJ	B-NP	O
code	code	NN	I-NP	O
.	.	.	O	O

Healthcare	Healthcare	NNP	B-NP	O
proxy	proxy	NN	I-NP	O
is	be	VBZ	B-VP	O
daughter	daughter	NN	B-NP	O
,	,	,	O	O
Wilford	Wilford	NNP	B-NP	O
A	A	NNP	I-NP	O
Greaux	Greaux	NNP	I-NP	O
.	.	.	O	O

Home	Home	NN	B-NP	O
phone	phone	NN	I-NP	O
number	number	NN	I-NP	O
is	be	VBZ	B-VP	O
192-580-8846	192-580-8846	CD	B-NP	O
,	,	,	O	O
work	work	NN	B-NP	O
number	number	NN	I-NP	O
581-425-7094	581-425-7094	CD	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Tylenol	Tylenol	NN	B-NP	O
650	650	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	RB	B-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

Ferrous	Ferrous	JJ	B-NP	O
sulfate	sulfate	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
daily	daily	RB	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Folic	Folic	JJ	B-NP	O
acid	acid	NN	I-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Lasix	Lasix	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Gabapentin	Gabapentin	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	B-protein
b.i.d.	b.i.d.	NN	I-NP	I-protein
8	8	CD	I-NP	I-protein
.	.	.	O	O

Insulin	Insulin	NN	B-NP	B-protein
NPH	NPH	NN	I-NP	I-protein
10	10	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcutaneous	subcutaneous	JJ	B-ADJP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Combivent	Combivent	VB	B-VP	O
2	2	CD	B-NP	O
puffs	puff	NNS	I-NP	O
inhaled	inhale	VBD	B-VP	O
four	four	CD	B-NP	O
times	time	NNS	I-NP	O
daily	daily	RB	B-ADVP	O
p.r.n.	p.r.n.	VBP	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
or	or	CC	O	O
wheezing	wheeze	VBG	B-VP	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
recovering	recover	VBG	I-VP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Isosorbide	Isosorbide	NN	B-NP	O
dinitrate	dinitrate	VBP	B-VP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
daily	daily	RB	I-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Xalatan	Xalatan	NN	B-NP	O
eye	eye	NN	I-NP	O
drops	drop	VBZ	B-VP	O
one	one	CD	B-NP	O
drop	drop	NN	I-NP	O
each	each	DT	B-NP	O
eye	eye	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

Metoprolol	Metoprolol	NN	B-NP	O
tartrate	tartrate	NN	I-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Oxycodone	Oxycodone	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
every	every	DT	B-NP	O
six	six	CD	I-NP	O
hours	hour	NNS	I-NP	O
p.r.n.	p.r.n.	JJ	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Senna	Senna	NNP	B-NP	O
tablets	tablet	VBZ	B-VP	O
two	two	CD	B-NP	O
tablets	tablet	NNS	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Simvastatin	Simvastatin	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

16	16	CD	B-NP	O
.	.	.	O	O

Multivitamin	Multivitamin	NN	B-NP	O
one	one	CD	I-NP	O
tablet	tablet	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

17	17	CD	B-NP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
3.5	3.5	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
MEDICATION	MEDICATION	NNP	I-NP	O
CHANGES	CHANGES	NNP	I-NP	O
MADE	MADE	NNP	I-NP	O
DURING	DURING	NNP	I-NP	O
THIS	THIS	NNP	I-NP	O
ADMISSION	ADMISSION	NNP	I-NP	O
:	:	:	O	O
Diltiazem	Diltiazem	NN	B-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

NPH	NPH	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
was	be	VBD	B-VP	O
reduced	reduce	VBN	I-VP	O
from	from	IN	B-PP	O
20	20	CD	B-NP	O
units	unit	NNS	I-NP	O
daily	daily	RB	B-ADVP	O
to	to	TO	B-PP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

A	A	DT	B-NP	O
multivitamin	multivitamin	NN	I-NP	O
was	be	VBD	B-VP	O
added	add	VBN	I-VP	O
.	.	.	O	O

Isosorbide	Isosorbide	NN	B-NP	O
dinitrate	dinitrate	NN	I-NP	O
was	be	VBD	B-VP	O
added	add	VBN	I-VP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
was	be	VBD	B-VP	O
added	add	VBN	I-VP	O
.	.	.	O	O

TO-DO	TO-DO	NNP	B-NP	O
LIST	LIST	NNP	I-NP	O
FOR	FOR	NNP	I-NP	O
REHAB	REHAB	NNP	I-NP	O
AND	AND	CC	O	O
VNA	VNA	NNP	B-NP	B-protein
:	:	:	O	I-protein
1	1	CD	B-NP	I-protein
.	.	.	O	O

Monitor	Monitor	NN	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Monitor	Monitor	NN	B-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Please	Please	NN	B-NP	B-protein
check	check	NN	I-NP	I-protein
INR	INR	NN	I-NP	I-protein
on	on	IN	B-PP	O
1/1/07	1/1/07	CD	B-NP	O
and	and	CC	O	O
every	every	DT	B-NP	O
two	two	CD	I-NP	O
to	to	TO	I-NP	O
three	three	CD	I-NP	O
days	day	NNS	I-NP	O
thereafter	thereafter	RB	B-ADVP	O
and	and	CC	O	O
adjust	adjust	VB	B-VP	O
the	the	DT	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
as	as	RB	B-ADJP	O
necessary	necessary	JJ	I-ADJP	O
for	for	IN	B-PP	O
target	target	NN	B-NP	O
INR	INR	NN	I-NP	O
of	of	IN	B-PP	O
2-3	2-3	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Please	Please	NN	B-NP	B-protein
do	do	VBP	B-VP	O
wound	wound	VB	I-VP	O
care	care	NN	B-NP	O
on	on	IN	B-PP	O
right	right	JJ	B-NP	O
buttocks	buttock	NNS	I-NP	O
and	and	CC	O	O
sacrum	sacrum	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
skin	skin	NN	I-NP	O
tear	tear	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
buttocks	buttock	NNS	I-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
stage	stage	NN	I-NP	O
I	I	CD	I-NP	O
decubitus	decubitus	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
sacrum	sacrum	NN	I-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Please	Please	VB	B-VP	O
apply	apply	VB	I-VP	O
DuoDERM	DuoDERM	NNP	B-NP	O
and	and	CC	O	O
do	do	VB	B-VP	O
wound	wound	JJ	B-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Please	Please	NN	B-NP	B-protein
have	have	VBP	B-VP	O
VNA	VNA	NN	B-NP	B-protein
do	do	VBP	B-VP	O
home	home	NN	B-NP	O
safety	safety	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
goes	go	VBZ	B-VP	O
home	home	NN	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
please	please	VB	B-VP	O
continue	continue	JJ	B-NP	O
physical	physical	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

FOLLOW-UP	FOLLOW-UP	JJ	B-NP	O
APPOINTMENTS	APPOINTMENTS	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Cedric	Cedric	NNP	I-NP	O
D	D	NNP	I-NP	O
Laite	Laite	NNP	I-NP	O
,	,	,	O	O
of	of	IN	B-PP	O
RDH	RDH	NN	B-NP	B-protein
.	.	.	O	O

His	His	PRP$	B-NP	O
office	office	NN	I-NP	O
is	be	VBZ	B-VP	O
aware	aware	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
needs	need	VBZ	B-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
one	one	CD	I-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
office	office	NN	I-NP	O
will	will	MD	B-VP	O
call	call	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
confirmation	confirmation	NN	B-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
appointment	appointment	NN	I-NP	O
.	.	.	O	O

Dr.	Dr.	NNP	B-NP	O
Petruso	Petruso	NNP	I-NP	O
office	office	NN	I-NP	O
number	number	NN	I-NP	O
is	be	VBZ	B-VP	O
568-490-2095	568-490-2095	CD	B-NP	O
.	.	.	O	O

CONTINUING	CONTINUING	VBG	B-VP	O
CARE	CARE	NN	B-NP	O
PLAN	PLAN	NN	I-NP	O
FOR	FOR	NN	I-NP	O
M.D.s	M.D.	NNS	I-NP	O
:	:	:	O	O
For	For	IN	B-PP	O
cardiologist	cardiologist	NN	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
final	final	JJ	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
amyloid	amyloid	JJ	B-NP	O
genetic	genetic	JJ	I-NP	O
test	test	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
final	final	JJ	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
bone	bone	NN	B-NP	O
marrow	marrow	NN	I-NP	O
biopsy	biopsy	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
final	final	JJ	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
heart	heart	NN	I-NP	O
biopsy	biopsy	NN	I-NP	O
including	include	VBG	B-PP	O
special	special	JJ	B-NP	O
stains	stain	NNS	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
Primary	Primary	NNP	B-NP	O
Care	Care	NNP	I-NP	O
Physician	Physician	NNP	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Manage	Manage	NN	B-NP	O
insulin	insulin	NN	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Follow	Follow	VB	B-VP	O
low	low	JJ	B-NP	O
back	back	JJ	I-NP	O
pain	pain	NN	I-NP	O
which	which	WDT	B-NP	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
chronic	chronic	JJ	B-ADJP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Follow	Follow	JJ	B-NP	O
decubitus	decubitus	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
stage	stage	NN	I-NP	O
I.	I.	NN	I-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

Follow	Follow	NNP	B-NP	O
INR	INR	NNP	I-NP	O
and	and	CC	O	O
adjust	adjust	JJ	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Monitor	Monitor	NN	B-NP	O
LFT	LFT	NN	I-NP	O
which	which	WDT	B-NP	O
appear	appear	VBP	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
chronically	chronically	RB	B-ADJP	O
elevated	elevated	JJ	I-ADJP	O
and	and	CC	O	O
workup	workup	NN	B-NP	O
as	as	RB	B-ADJP	O
necessary	necessary	JJ	I-ADJP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Question	Question	NN	B-NP	O
of	of	IN	B-PP	O
restless	restless	JJ	B-NP	O
leg	leg	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
.	.	.	O	O

Please	Please	NN	B-NP	O
reassess	reassess	NN	I-NP	O
and	and	CC	I-NP	O
treat	treat	NN	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Monitor	Monitor	NN	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
and	and	CC	I-NP	O
platelets	platelet	NNS	I-NP	B-cell_type
.	.	.	O	O

An	An	DT	B-NP	O
addendum	addendum	NN	I-NP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
stat	stat	NN	I-NP	O
dictation	dictation	NN	I-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
discharge	discharge	NN	I-NP	O
is	be	VBZ	B-VP	O
confirmed	confirm	VBN	I-VP	O
including	include	VBG	B-PP	O
a	a	DT	B-NP	O
finalized	finalize	VBN	I-NP	O
medication	medication	NN	I-NP	O
list	list	NN	I-NP	O
for	for	IN	B-PP	O
discharge	discharge	NN	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
final	final	JJ	I-NP	O
discharge	discharge	NN	I-NP	O
weight	weight	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
4-4098863	4-4098863	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Omar	Omar	NNP	B-NP	O
Arnstein	Arnstein	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
Kaihend	Kaihend	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
Tuc	Tuc	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
BITTING	BITTING	NNP	B-NP	O
,	,	,	O	O
JORDAN	JORDAN	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
HARCOURT	HARCOURT	NN	B-NP	O
,	,	,	O	O
DALE	DALE	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
8373005	8373005	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
7/11/07	7/11/07	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
7/11/07	7/11/07	CD	B-NP	O

